Marc Lalancette
Quebec, QC G1V0E8, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma.
Journal: Current oncology (Toronto, Ont.)
Published: March 29, 2025
Switching TKIs during CML therapy is frequent, mostly driven by intolerance, and does not affect survival: a prospective Quebec registry study.
Journal: Blood cancer journal
Published: November 11, 2024
Outcomes of adults with refractory or relapsed acute myeloid leukemia treated with azacitidine and venetoclax compared to other therapies: a multicenter retrospective study.
Journal: Leukemia & lymphoma
Published: August 12, 2024
Comparison of Weekly Paclitaxel Regimens in Recurrent Platinum-Resistant Ovarian Cancer: A Single Institution Retrospective Study.
Journal: Current oncology (Toronto, Ont.)
Published: July 03, 2024
Poor outcome despite modern treatments: A retrospective study of 99 patients with primary and secondary plasma cell leukemia.
Journal: Cancer medicine
Published: February 25, 2024
A descriptive cost-analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high-dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma.
Journal: European journal of haematology
Published: March 23, 2021
Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN-003/MYX.1 single arm phase II trial.
Journal: American journal of hematology
Published: November 28, 2020
Drug-induced Thrombotic Microangiopathy with Concurrent Proteasome Inhibitor Use in the Treatment of Multiple Myeloma: A Case Series and Review of the Literature.
Journal: Clinical lymphoma, myeloma & leukemia
Published: February 24, 2020
Variability and bias between magnetoencephalography systems in localization of the primary visual cortex.
Journal: Clinical neurology and neurosurgery
Published: August 16, 2019
Canadian chronic myeloid leukemia outcomes post-transplant in the tyrosine kinase inhibitor era.
Journal: Leukemia research
Published: May 25, 2018
Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX.
Journal: Haematologica
Published: March 27, 2018
Variability and bias between magnetoencephalography systems in non-invasive localization of the primary somatosensory cortex.
Journal: Clinical neurology and neurosurgery
Published: March 21, 2018
Last Updated: 09/26/2026